Yakult Honsha And OncoTherapy Science, Inc. To Team Up In R&D For New Antibody Drugs For Lung Cancer Treatments
10/19/2005 5:11:05 PM
Yakult Honsha has announced that it has agreed with OncoTherapy Science to collaborate in R&D in the field of antibody drugs for cancer treatments.
Under this alliance, the two companies will strive to develop new antibody drugs aimed at the treatment of lung cancer.
comments powered by